Current Status of Medicinal Plants Amaranthus viridis and Mikania micrantha: A Review

The current status of medicinal plants have a unavoidable parameter for the treatment of certain diseases. A plant of the family Amaranthaceae used as a traditional medicine on the treatment of antipyretic, anti-inflammatory, antidiabetic, antioxidant is Amaranthus viridis. Mikania micrantha is an insecticide-resistant species of plant which has demonstrated many health benefits, such as antimicrobial, antifungal, antioxidant, anti-inflammatory, antidiabetic and wound healing activity or dermatological activity. Amaranthus viridis produce various biological activity due to present of some important phytoconstituents such as alkaloids, flavonoids, phenolic compounds, saponins, tannins triterpenoids, cardiac glycosides, glycosides (general), anthraquinones, resin. Mikania micrantha is responsible for different pharmacological property which may be occurs due to presence of flavonoids, tannins, terpenoids, cardiac glycosides, phenolic compounds, saponins. Both plant has not undergone clinical trial in human beings. The research studies in future should cover significant issues. It must address the high chemitoxic variability of phytochemicals in the two species by standardizing with markers. It is also important to clarify safety profiles. It is particularly so in the case of the chronic nephrotoxic risk linked to A. viridis, and the safety of the allelochemicals of M. micrantha across the system.